Cargando…
Current status of traditional Chinese medicine for the treatment of COVID-19 in China
An ongoing outbreak of severe respiratory illness and pneumonia caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) commenced in December 2019, and the disease was named as coronavirus disease 2019 (COVID-19). Soon after, scientists identified the characteristics of SARS-CoV-2, includi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314260/ https://www.ncbi.nlm.nih.gov/pubmed/34315521 http://dx.doi.org/10.1186/s13020-021-00461-y |
_version_ | 1783729509512511488 |
---|---|
author | Chu, Liang Huang, Fang Zhang, Mengdan Huang, Biao Wang, Yigang |
author_facet | Chu, Liang Huang, Fang Zhang, Mengdan Huang, Biao Wang, Yigang |
author_sort | Chu, Liang |
collection | PubMed |
description | An ongoing outbreak of severe respiratory illness and pneumonia caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) commenced in December 2019, and the disease was named as coronavirus disease 2019 (COVID-19). Soon after, scientists identified the characteristics of SARS-CoV-2, including its genome sequence and protein structure. The clinical manifestations of COVID-19 have now been established; and nucleic acid amplification is used for the direct determination of the virus, whereas immunoassays can determine the antibodies against SARS-CoV-2. Clinical trials of several antiviral drugs are ongoing. However, there is still no specific drugs to treat COVID-19. Traditional Chinese medicine (TCM) was used in the treatment of COVID-19 during the early stages of the outbreak in China. Some ancient TCM prescriptions, which were efficacious in the treatment of severe acute respiratory syndrome (SARS) in 2002–03 and the influenza pandemic (H1N1) of 2009, have been improved by experienced TCM practitioners for the treatment of COVID-19 based on their clinical symptoms. These developed new prescriptions include Lianhua Qingwen capsules/granules, Jinhua Qinggan granules and XueBiJing injection, among others. In this review, we have summarized the presenting features of SARS-CoV-2, the clinical characteristics of COVID-19, and the progress in the treatment of COVID-19 using TCMs. |
format | Online Article Text |
id | pubmed-8314260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83142602021-07-27 Current status of traditional Chinese medicine for the treatment of COVID-19 in China Chu, Liang Huang, Fang Zhang, Mengdan Huang, Biao Wang, Yigang Chin Med Review An ongoing outbreak of severe respiratory illness and pneumonia caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) commenced in December 2019, and the disease was named as coronavirus disease 2019 (COVID-19). Soon after, scientists identified the characteristics of SARS-CoV-2, including its genome sequence and protein structure. The clinical manifestations of COVID-19 have now been established; and nucleic acid amplification is used for the direct determination of the virus, whereas immunoassays can determine the antibodies against SARS-CoV-2. Clinical trials of several antiviral drugs are ongoing. However, there is still no specific drugs to treat COVID-19. Traditional Chinese medicine (TCM) was used in the treatment of COVID-19 during the early stages of the outbreak in China. Some ancient TCM prescriptions, which were efficacious in the treatment of severe acute respiratory syndrome (SARS) in 2002–03 and the influenza pandemic (H1N1) of 2009, have been improved by experienced TCM practitioners for the treatment of COVID-19 based on their clinical symptoms. These developed new prescriptions include Lianhua Qingwen capsules/granules, Jinhua Qinggan granules and XueBiJing injection, among others. In this review, we have summarized the presenting features of SARS-CoV-2, the clinical characteristics of COVID-19, and the progress in the treatment of COVID-19 using TCMs. BioMed Central 2021-07-27 /pmc/articles/PMC8314260/ /pubmed/34315521 http://dx.doi.org/10.1186/s13020-021-00461-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Chu, Liang Huang, Fang Zhang, Mengdan Huang, Biao Wang, Yigang Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title | Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title_full | Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title_fullStr | Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title_full_unstemmed | Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title_short | Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
title_sort | current status of traditional chinese medicine for the treatment of covid-19 in china |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314260/ https://www.ncbi.nlm.nih.gov/pubmed/34315521 http://dx.doi.org/10.1186/s13020-021-00461-y |
work_keys_str_mv | AT chuliang currentstatusoftraditionalchinesemedicineforthetreatmentofcovid19inchina AT huangfang currentstatusoftraditionalchinesemedicineforthetreatmentofcovid19inchina AT zhangmengdan currentstatusoftraditionalchinesemedicineforthetreatmentofcovid19inchina AT huangbiao currentstatusoftraditionalchinesemedicineforthetreatmentofcovid19inchina AT wangyigang currentstatusoftraditionalchinesemedicineforthetreatmentofcovid19inchina |